Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2022; 47(3): 560-563


Metabolic syndrome among pre and post-menopausal women according to NCEP ATP-III & IDF criteria: A comparative analysis

Khalida Shaikh, Zulfiqar Ali Laghari, Jamshed Warsi.




Abstract

Objective: To compare the prevalence of metabolic syndrome (MetS) amongst pre- menopausal and post-menopausal women according to NCEP: ATPIII & International Diabetes Federation (IDF) criteria.
Methodology: This cross-sectional study was done on a sample of 278 (147 premenopausal & 131 postmenopausal) women (25 years and above) presenting to the Outpatient Department of Liaquat University Hospital, Hyderabad from February to October 2020. We used a structured interview-based questionnaire containing inquiries pertaining to basic biodata, sociodemographic details and menstrual history. All anthropometric measurements along with visceral & body fat level were calculated using measuring tape & OMRON BfF508. Data were analyzed using SPSS 23.
Results: Cumulative MetS prevalence was 63.7% and 57.6% according to IDF (WC80 diagnostic criteria) and NCEP ATP-III classifications, respectively. Prevalence of MetS in premenopausal, was 24.5% according to IDF criteria and 21.24% according to ATP-III, criteria. Among postmenopausal, prevalence of MetS was 39.2% according to IDF criteria, and 36.36 according to NCEP ATP-III criteria.
Conclusion: MetS is more common among post-menopausal women. It is also observed in pre-menopausal women at alarming rates. IDF suggests significantly higher prevalence of MetS in participants as compared to ATP III criteria.

Key words: Metabolic syndrome, menopause, visceral & body Fat, NCEP ATP-III Classification, IDF Criteria.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.